Clinical Trial Detail

NCT ID NCT03315039
Title Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Moleculin Biotech, Inc.
Indications

acute myeloid leukemia

Therapies

Liposomal Annamycin

Age Groups: senior adult

No variant requirements are available.